Andrew Schorr, cofounder and president of Patient Power, spoke at the Precision Medicine World Conference where he emphasized the importance of scientists, business leaders, and investors involved with genomic testing and next-generation sequencing to raise awareness of medical advances with cancer patients. Self-advocating patients can achieve better treatment with a greater knowledge of options or promising trials but most are unaware of such medical advances, a problem that can be fixed with greater transparency. Click here to read more.
Last Updated on May 12, 2020 by Aimed Alliance
